Jeffrey H. Porter - 16 May 2025 Form 4 Insider Report for cbdMD, Inc. (YCBD)

Role: Director
Signature: /s/ Jeffrey Porter
Issuer symbol: YCBD
Transactions as of: 16 May 2025
Net transactions value: $0
Form type: 4
Filing time: 20 May 2025, 17:23:40 UTC
Previous filing: 08 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Porter Jeffrey H	Director	2101 WESTINGHOUSE BLVD. SUITE A, CHARLOTTE	/s/ Jeffrey Porter	20 May 2025	0002065626

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Ownership	Footnotes
transaction	YCBD	Common Stock	Award	$0	+1,572	$0.000000	1,572	16 May 2025	Direct	F1
holding	YCBD	Common Stock					465,955	16 May 2025	By Porter Partners L.P.	F2
holding	YCBD	Common Stock					61,750	16 May 2025	By Ben Joseph Partners	F2
holding	YCBD	Common Stock					41,275	16 May 2025	By Jeff Porter IRA-Beneficiary	F2
holding	YCBD	Common Stock					4,550	16 May 2025	By Beneficiary of Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors.
F2	Represents shares of common stock held by an entity for which the Reporting Person holds voting and dispositive control.

Content

Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors.

Represents shares of common stock held by an entity for which the Reporting Person holds voting and dispositive control.